𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy

✍ Scribed by G Murphy

Book ID
117453856
Publisher
Elsevier Science
Year
1997
Tongue
French
Weight
147 KB
Volume
1997
Category
Article
ISSN
0294-3506

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunotherapy with dendritic cells for p
Immunotherapy with dendritic cells for prostate cancer
✍ Anna-Katharina Thomas-Kaskel; Cornelius F. Waller; Wolfgang Schultze-Seemann; He πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 152 KB

## Abstract Radical prostatectomy for prostate cancer is followed by PSA recurrence in up to 40% of patients. One third of patients with biochemical relapse progress to uncurable metastatic disease. Therefore, alternative treatment modalities are needed both in the situation of PSA recurrence and i

Dendritic cell-based immunotherapy for p
Dendritic cell-based immunotherapy for prostate cancer
✍ Dr. Benjamin A. Tjoa; Dr. Patricia A. Lodge; Dr. Michael L. Salgaller; Dr. Alton πŸ“‚ Article πŸ“… 1999 πŸ› American Cancer Society 🌐 English βš– 167 KB
Dendritic Cells for the Immunotherapy of
Dendritic Cells for the Immunotherapy of Cancer
✍ Alan Melcher; Andrew Bateman; Kevin Harrington; Atique Ahmed; Michael Gough; Ric πŸ“‚ Article πŸ“… 2002 πŸ› Elsevier Science 🌐 English βš– 109 KB
Exploiting dendritic cells for cancer im
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells
✍ Karine Breckpot; Carlo Heirman; Bart Neyns; Kris Thielemans πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 579 KB

## Abstract Dendritic cells (DCs) are pivotal regulators of immune reactivity and immune tolerance. The observation that DCs can recruit naive T cells has invigorated cancer immunology and led to the proposal of DCs as the basis for vaccines designed for the treatment of cancer. Designing effective